Our current model proposes that EP3 and EP4 play opposing roles in the heart and that shifting the balance toward increased EP4 activity will be beneficial in the setting of diabetic cardiomyopathy. This evidence concerns the gene PTGER4 and diabetic cardiomyopathy.